Share on StockTwits

GTx (NASDAQ:GTXI) CEO Marc Steven Hanover acquired 10,000 shares of the stock on the open market in a transaction that occurred on Tuesday, August 19th. The shares were purchased at an average price of $1.01 per share, with a total value of $10,100.00. Following the completion of the purchase, the chief executive officer now directly owns 178,138 shares in the company, valued at approximately $179,919. The purchase was disclosed in a document filed with the SEC, which is available at this link.

GTx (NASDAQ:GTXI) traded up 2.00% during mid-day trading on Tuesday, hitting $1.02. 96,161 shares of the company’s stock traded hands. GTx has a one year low of $0.81 and a one year high of $2.36. The stock’s 50-day moving average is $1.22 and its 200-day moving average is $1.46. The company’s market cap is $77.5 million.

GTx (NASDAQ:GTXI) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.15) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.12) by $0.03. During the same quarter last year, the company posted ($0.20) earnings per share. On average, analysts predict that GTx will post $-0.48 earnings per share for the current fiscal year.

GTx, Inc is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (NASDAQ:GTXI) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.